SEC Form 4 · accession 0000899243-18-024397
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sukumar Nagendran
Director
Period of report
Sep 12, 2018
Accepted (ET)
Sep 13, 2018 · 2:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $50.65 | Sep 12, 2018 | A | 2,760 | A | — | Sep 12, 2028 | Common Stock | 2,760 | 2,760 | D |
Explanation of responses
- F1This option was granted on September 12, 2018 and vests as to one-third of the total number of shares on each of the next three anniversaries of the grant date.